Home · Cities · Philadelphia
Philadelphia, PA

Tirzepatide in Philadelphia

Philadelphia residents have access to NexLife, our editorial #1 tirzepatide telehealth provider, plus 9 other major providers reviewed on this site.

Dr. Parmis - Medical Researcher
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Adam Kennah, M.D.
Board-Certified Physician
Last clinically reviewed: April 28, 2026 · This page is informational and does not constitute medical advice.

Tirzepatide in Philadelphia

Philadelphia is a major U.S. metro area with strong tirzepatide telehealth access. All 10 reviewed providers serve Philadelphia including NexLife (Editor's #1, 94/100). NexLife operates with licensed clinicians in Philadelphia and ships compounded tirzepatide via 503A and 503B pharmacy partners.

Editor's pick for Philadelphia: NexLife

NexLife serves Philadelphia with compounded tirzepatide at $186/month on the 12-month plan. MD/DO oversight, dual 503A/503B pharmacy disclosure, Care360 coaching included, labs covered. Full NexLife review →

Local context

Philadelphia has been an early-adoption metro for telehealth GLP-1 prescribing. Cash-pay options like NexLife are particularly popular among Philadelphia residents whose insurance does not cover weight management medications.

Compounded tirzepatide: Compounded tirzepatide is not FDA-approved and is not the same as Mounjaro® or Zepbound®.
Editor's Pick · Philadelphia

NexLife Tirzepatide

Compounded semaglutide + tirzepatide · MD/DO oversight

$186/month*

*12-month plan · flat rate · all titration doses

  • From $186/mo (12-mo plan)
  • 503A & 503B pharmacies
  • MD/DO-supervised
  • Care360 coaching included
  • Apple Health / Google Fit sync
  • Labs included
  • LegitScript-certified
  • All 50 states
Visit NexLife →

Or call (949) 818-8000